Early tumour response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma

British Journal of Radiology

Volumn 69, Issue 819, 1996, Pages 241-248

  Teo, P M L ^a   Kwan, W H ^a   Leung, S F ^a   Leung, W T ^a   Chan, A ^a   Choi, P ^a   Yu, P ^a   Lee, W Y ^a   Johnson, P ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; INTERMETHOD COMPARISON; LYMPH VESSEL; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; NASOPHARYNX CARCINOMA; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; TIME;

EID: 0029882797     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/0007-1285-69-819-241     Document Type: Article

References (43)

1. HO, J H C, Nasopharynx, In Treatment of Cancer, ed. by K E Halnan, ET AL (Igaku-shoin, New York), pp. 249-267 (1982).
2. LEE, A W M, LAW, S C K, FOO, W ET AL, Nasopharyngeal carcinoma: local control by megavoltage irradiation, Br. J. Radiol., 66, 528-536 (1993).
3. LEE, A W M, POON, Y F, FOO, W ET AL, Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure, Int. J. Radiat. Oncol. Biol. Phys., 23, 261-270 (1992).
4. SHAM, J S T and CHOY, D, Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients, Br. J. Radiol., 63, 51-58 (1990).
5. TEO, P, TSAO, S Y, SHIU, W ET AL, A clinical study of 407 cases of nasopharyngeal carcinoma in Hong Kong, Int. J. Radiat. Oncol. Biol. Phys., 17, 515-530 (1989).
6. HO, J H C, Nasopharyngeal cancer. In UICC Monograph Series Vol. 1, No. 35, ed. by C S Muir and K Shanmugaratnam (Medical Examination Publishing Co. Inc., New York), pp 238-246 (1967).
7. KWONG, D, SHAM, J and CHOY, D, The effect of locoregional control on distant metastatic dissemination in carcinoma of the nasopharynx: An analysis of 1301 patients, Proc. 2nd EORTC International Hong Kong Symposium on current trends in cancer care, 13-15 February 1995, p. 60 (1995).
8. YU, K H, TEO, P M L, LEE, W Y ET AL, Patterns of early treatment failure in non-metastatic nasopharyngeal carcinoma: a study based on CT scanning, Clin. Oncol., 6, 167-171 (1994).
9. CHOY, D, SHAM, J S T, WEI, W I ET AL, Transpalatal insertion of radioactive gold grain for the treatment of persistent and recurrent nasopharyngeal carcinoma, Int. J. Radiat. Oncol. Biol. Phys., 25, 505-512 (1993).
10. LEE, A W M, Complications of radiation therapy. In Nasopharyngeal Carcinoma, ed. by C A Van Hasselt and A G Gibb (The Chinese University Press: Hong Kong), pp. 221-234 (1991).
11. LEE, A W M, LAW, S C K, FOO, W ET AL, Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence, Int J. Radiat. Oncol. Biol. Phys., 26, 773-782 (1993).
12. WEI, W I, LAM, K H and SHAM, J S T, New approach to the nasopharynx: the maxillary swing approach, Head Neck, 13, 200-207 (1991).
13. ANG, K K, PETERS, L J, WEBER, R S ET AL, Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx, Int. J. Radiat. Oncol. Biol Phys., 19, 1339-1345 (1990).
14. COX, J D, PAJAK, T F, MARCIAL, V A ET AL, ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group Protocol 8313, Int. J. Radiat. Oncol. Biol. Phys., 20, 1191-1195 (1991).
15. DATTA, N R, CHOUDRY, A D, GUPTA, S and BOSE, A K, Twice a day versus once a day radiation therapy in head and neck cancer (Abstract), Int J. Radiat. Oncol. Biol. Phys., 17 (Suppl 1), 132-133 (1989).
16. HORIOT, J C, LEFUR, R, N'GUYEN, T ET AL, Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy, Radiother. Oncol., 25, 231-241 (1992).
17. KNEE, R, FIELDS, R S and PETERS, L J, Concomitant boost radiotherapy for advanced squamous cell carcinoma of the head and neck, Radiother. Oncol., 4, 1-7 (1985).
18. PARSONS, J T, MENDENHALL, W M, CASSISI, N J ET AL, Hyperfractionation for head and neck cancer, Int. J. Radiat. Oncol. Biol. Phys., 14, 649-658 (1988).
19. COX, J D, PAJAK, T F and MARCIAL, V A, Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts, Cancer, 69, 2744-2748 (1992).
20. PETERS, L J, ANG, K K and THAMES, H D, JR, Accelerated fractionation in the radiation treatment of head and neck cancer: a critical comparison of different strategies, Acta Oncol., 27, 185-194 (1988).
21. SAUNDERS, M I, DISCHE, S, FOWLER, J F ET AL, Radiotherapy employing three fractions on each of twelve consecutive days, Acta Oncol., 27, 163-167 (1988).
22. WANG, C C, Local control of oropharyngeal carcinoma after two accelerated hyperfractionation on radiation therapy schemes, Int. J. Radiat Oncol. Biol. Phys., 14, 1143-1146 (1988).
23. HORIOT, J C, LEFUR, R and SCHRAUB, S, Status of the experience of the EORTC co-operative group of radiotherapy with hyperfractionated and accelerated radiotherapy regimes, Semin. Radiat. Oncol., 2, 34-37 (1992).
24. FOWLER, J F, The second Klaas Breur Memorial Lecture: LaRonde - radiation sciences and medical radiology, Radiother. Oncol., 1, 1-22 (1983).
25. WILLIAMS, M V, DENEKAMP, J and FOWLER, J F, A review of alpha beta ratios for experimental tumours: implications for clinical studies of altered fractionation, Int. J Radiat. Oncol. Biol. Phys., 11, 87-96 (1985).
26. WANG, C C, Accelerated hyperfractionation radiation therapy for carcinoma of the nasopharynx. Technique and results, Cancer, 63, 2461-2467 (1989).
27. TEO, P, SHIU, W, LEUNG, S F and LEE, W Y, Prognostic factors in nasopharyngeal carcinoma investigated by computer tomography - an analysis of 659 patients, Radiother. Oncol , 23, 79-93 (1992).
28. LEUNG, S F, KREEL, L and TSAO, S Y, Asymptomatic temporal lobe injury after radiotherapy for nasopharyngeal carcinoma: incidence and determinants, Br. J. Radiol., 65, 710-714 (1992).
29. HO, J H C, Stage classification of nasopharyngeal carcinoma. In Nasopharyngeal Carcinoma, Etiology and Control, ed. by G de The and Y Ito (IARC Scientific Publications, Lyon), pp. 99-113 (1978).
30. FU, K K, Prognostic factors of carcinoma of the nasopharynx, Int. J. Radiat. Oncol. Biol. Phys., 6, 523-526 (1980)
31. HUANG, S C, Nasopharyngeal cancer: a review of 1605 patients treated radically with cobalt 60, Int. J. Radiat. Oncol. Biol. Phys., 6, 401-407 (1980).
32. TEO, P, TSAO, S Y, HO, J H C and YU, P, A proposed modification of the Ho Stage-classification for nasopharyngeal carcinoma, Radiother. Oncol., 21, 11-23 (1991).
33. SILVER, A J, MAWAD, M E, HILAL, S K ET AL, Computed tomography of the nasopharynx and related spaces, Radiology, 147, 725-731 (1983).
34. FOWLER, J F, The linear-quadratic formula and progress in fractionated radiotherapy, Br. J. Radiol., 62, 679-694 (1989).
35. MARCIAL, V A, PAJAK, T F, CHANG, C ET AL, Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the radiation therapy oncology group (RTOG), Int. J. Radiat. Oncol. Biol. Phys., 13, 141-47 (1987).
36. WITHERS, H R, TAYLOR, J M G and MACIEJEWSKI, B, The hazard of accelerated tumour clonogen repopulation during radiotherapy, Acta Oncol., 27, 131-146 (1988).
37. LEE, A W M, NG, S H, HO, J H C ET AL, Clinical diagnosis of late temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma, Cancer, 61, 1535-1542 (1988).
38. BARKLEY, H T JR and FLETCHER, G H, The significance of residual disease after external irradiation of squamous-cell carcinoma of the oropharynx, Radiology, 124, 493-495 (1977).
39. BATAINI, J P, BERNIER, J, JAULERRY, C ET AL, Impact of neck node radioresponsiveness on the regional control probability in patients with oropharynx and pharyngolarynx cancer managed by definitive radiotherapy, Int. J Radiat. Oncol. Biol. Phys., 13, 817-824 (1987).
40. BATAINI, J P, JAULERRY, C, BRUNIN, F ET AL, Significance and therapeutic implications of tumour regression following radiotherapy in patients treated for squamous cell carcinoma of the oropharynx and pharyngolarynx, Head Neck, 12, 41-49 (1990).
41. SOBEL, S, RUBIN, P, KELLER, B and POULTER, C, Tumour persistence as a predictor of outcome after radiation therapy of head and neck cancers, Int. J. Radiat. Oncol. Biol. Phys., 1, 873-880 (1976).
42. SAUNDERS, M I, DISCHE, S, GROSCH, E J ET AL, Experience with Chart, Int. J. Radiat. Oncol. Biol Phys., 21, 871-878 (1991).
43. SHAM, J, CHOY, D, KWONG, P W K ET AL, Radiotherapy for nasopharyngeal carcinoma: shielding the pituitary may improve therapeutic ratio, Int. J. Radiat. Oncol. Biol. Phys., 29, 699-704 (1994).